Research Alliances
In recent years, pharmaceutical discovery has come to require a combination of technologies from a number of specialized fields. While continuing to improve its own R&D capabilities, Takeda actively pursues alliances with other pharmaceutical manufacturers, biotechnology companies, universities, and other research institutions to efficiently introduce key technologies.
Research Alliances with overseas research organizations and companies
| Partner | Country | Research subject | Schedule |
| Oxford Centre for Diabetes, Endocrinologyand Metabolism | U.K. | Partnership with Oxford Diabetes Centre | 2002/4- |
| Beth Israel Deaconess Medical Center | U.S | Joint collaboration on diabetes and obesity field | 2002/4- |
| XOMA Ltd. | U.S | Joint research on discovery, development and production technologies of monoclonal antibody | 2006/11- |
| LG Life Sciences | S. Korea | Joint collaboration on anti-obesity drugs | 2007/3- |
| Archemix Corp. | U.S. | Collaboration for Discovery and Development of AptamerTherapeutics | 2007/6-2010/6 |
| Alnylam Pharmaceuticals, Inc. | U.S. | Collaboration for Discovery and Development of RNAi Therapeutics | 2008/5-2013/5 |
| Seattle Genetics | U.S. | Research collaboration on Antibody-Drug Conjugate | 2009/3- |
| University of Washington | U.S. | Joint collaboration on anti-obesity drugs | 2009/3-2012/3 |
| CellCentric | U.K. | Exclusive licensing of one of the CellCentric’s epigenetics projects for the development and commercialization in oncology field. | 2010/2- |
| Dimerix | Australia | Research collaboration on searching of GPCR for development of products | 2010/3- |
| British Columbia Cancer Agency | Canada | Research collaboration for discovery of novel candidate targets for cancer treatment | 2010/3-2013/3 |
| University College London | U.K. | Research collaboration on development of novel cancer treatment | 2010/3-2014/3 |
| University College London | U.K. | Research collaboration in ophthalmologic disease | 2010/3-2014/3 |
| Metabolex, Inc. | U.S. | Research collaboration on evaluation and validation of protein targets for development of biological products | 2010/4- |
| Envoy Therapeutics Inc. | U.S. | Research collaboration on discovering new drug targets for schizophrenia with Envoy’s “bacTRAP®” technology |
2010/10-2013/10 |
（*）Roche and Arius Research Inc. announced that the two companies have signed a definitive agreement for Roche to acquire Arius on July 23, 2008.
Research Alliances with domestic research organizations and companies
| Partners | Research subject | Schedule |
| Osaka University | Development of novel diagnostics of lifestyle-related diseases by novel secretory factors | Apr 04- Mar 07 |
| Kyoto University | Kyoto Cell / Biodynamic Simulation | Oct 03- Mar 08 |
| Kirin Brewery (Now Kyowa Hakko Kirin) | Licensing-in of the human antibody technology | Jul 03 - |
| Keio University | Target discovery for molecules differentiating neuronal stem cells to neurons | Apr 03- Mar 06 |
| RIKEN (The Institute of Physical and Chemical Research) | Analysis of SNPs related to pioglitazone-induced edema | Feb 03- Mar 06 |
| RIKEN (The Institute of Physical and Chemical Research) | Research for human genome relating to osteoarthritis | Jul 02- Mar 05 |
| Keio University | Research for human genome relating to hypertension and diabetic organopathy | Mar 02- Feb 05 |
| Shin Nippon Biomedical Laboratories | Research for toxico-genomics | Jan 02- Jan 06 |
| Biomolecular Engineering Research Institute | Research for application of biomolecular functions | Jun 01- Mar 06 |
| Kagoshima University | Joint research on efficacy evaluation of anti-HIV drugs | Oct 97- Mar 05 |